基于模型的心脏剂量估算在左侧乳腺癌放射治疗中的应用
本研究纳入147例左侧乳腺癌仰卧位切线野治疗患者,利用无CT的二维X线片和最大心脏距离(MHD)与受照心脏面积(AREA)建立线性及二次数学模型估算心脏剂量。结果显示模型估算值与三维计划系统计算值误差在±3%以内,MHD和AREA与Dmean及V10-V50相关性好(线性模型R²>0.91,二次模型R²>0.92)。
要点
- MHD和AREA与心脏Dmean及V10-V50线性模型R²>0.91,二次模型R²>0.92。
- 基于二维X线片的模型估算心脏剂量误差多数病例<3%,总体在±3%以内。
- 该模型可用于无CT数据患者的既往放疗心脏剂量回顾估算。
核心结论
- 所提出的心脏剂量估算数学模型在无CT数据时利用X线片估算的误差在±3%以内,可为放疗剂量与心脏毒性相关研究提供患者pooling途径,并有助于从既往研究和仍使用二维计划的中心准确估算心脏剂量。
研究设计与样本
- 经机构审查委员会批准,选取147例左侧乳腺癌仰卧位对穿切线野治疗患者,移除切线野心脏挡块后使用6 MV束流和先进算法进行剂量计算;研究使用CT数据生成DRR以模拟既往治疗的X线模拟机图像,创建显示勾画乳腺、肺和心脏的射野方向观图像以代表X线片视图;记录最大心脏距离(MHD),通过三角形和矩形组合计算受照心脏面积(AREA);基于精确三维剂量计算,分析心脏平均剂量(Dmean)及V10至V50与MHD和AREA的剂量学参数关系,采用线性与二次拟合。
诊断标准与关键数值
- MHD和AREA与Dmean、V10、V20、V30和V50的线性模型相关性很好(R²>0.91),二次模型相关性显著更好(R²>0.92);线性与二次模型的剂量学误差分析显示大多数病例误差<3%;所提出的心脏剂量估算数学模型使用无CT数据的X线片准确度在±3%以内;由MHD和二维X线片分段计算的治疗参数与三维计划系统计算的实际剂量学参数差异在2%以内。
临床应用与阅片要点
- 作者指出该模型可为放疗剂量与心脏毒性相关研究提供患者pooling途径,并有助于从既往研究及仍使用二维计划的中心准确估算心脏剂量分析。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: To develop a mathematical model for cardiac dose estimation for patients who have been treated for left-sided breast cancer without CT data.
METHODS:: After obtaining institutional review board approvals, 147 patients with left-sided breast cancer were selected that were treated supine with opposed tangents. The heart blocks from the tangential fields were removed and dose calculations were performed with 6 MV beams using an advanced algorithm. This study was performed with CT data with DRR to represent a radiographic simulator image of yesteryear treatments. The beam's eye-view images showing delineated breast, lung and heart were created to represent views on radiograph. The maximum heart distance (MHD) was recorded and irradiated heart area (AREA) was computed by combination of triangles and rectangles. Based on accurate 3D dose calculation, mean dose (Dmean) and V10 to V50 of heart were analyzed with respect to MHD and AREA for dosimetric parameters using linear and quadratic fit.
RESULTS:: The treatment parameters calculated by MHD and segments using 2D radiographs were within 2% of the actual dosimetric parameters computed from the 3D planning system. The MHD and AREA vs Dmean, V10, V20, V30 and V50 showed very good correlation with linear model (R2 > 0.91); however the correlation was significantly better with quadratic model (R2 > 0.92). The analysis of the dosimetric error with our linear and quadratic model is remarkable within <3% error for most cases.
CONCLUSION:: The proposed mathematical model for the cardiac dose estimation is accurate within ±3% using a radiograph without CT data. This provides avenues for patient pooling in future studies related to radiation dose and cardiac toxicity. These results will help in estimating cardiac dose analysis accurately from previous studies as well as in centers still using 2D planning.
ADVANCES IN KNOWLEDGE:: The evidence of cardiac risk following radiotherapy continues to be one of the important considerations for the management of left-sided breast cancer patients. One of the problem in the estimation of dose-risk effects is the reconstruction of heart dose for pre-CT treatments. In this study, a simple mathematical model is presented that could estimate cardiac dose within ±3% in left breast cancer treatment from 2D radiograph where CT data do not exist.
引用
- Ueda Y, Gerber NK, Das IJ, et al. Model-based cardiac dose estimation in radiation treatment of left breast cancer. Br J Radiol. 2018. PMID: 30044144. doi:10.1259/bjr.20180287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。